Genital Warts Therapeutics Market: Physical destruction segment to dominate the market

Genital warts are a common sexually transmitted infection caused by the human papillomavirus (HPV).

Genital Warts Therapeutics Market: Introduction

  • Genital warts are a common sexually transmitted infection caused by the human papillomavirus (HPV). Nearly all sexually active people are likely to become infected with at least one type of human papillomavirus (HPV), the virus that causes genital warts, at some point during their lives. Some strains of genital HPV can cause genital warts, while others can cause cancer.

Read Report Overview - https://www.transparencymarketresearch.com/genital-warts-therapeutics-market.html

Key Drivers and Restraints of Global Genital Warts Therapeutics Market

  • Increase in prevalence of warts & HPV infections drive the market. People with weakened immune system due to organ transplant, serious diseases such as cancer or AIDS, and atopic diseases are at a greater risk of developing warts. Thus, an increase in the number of people with cancer increases the prevalence of warts, and thereby drives the market. For instance, according to the Anal Cancer Foundation, each year, an estimated 14 million people are infected with HPV in the U.S. As per the Centers for Disease Control and Prevention, in the U.S., approximately 340,000 to 360,000 women and men were affected by genital warts caused by HPV every year, and it typically develops approximately 2 to 3 months after the HPV infection.
  • Recurrence of warts increases the demand for treatment. Several treatments are available for warts. However, recurrences are common. A high number of cases of genital warts fail to respond to treatment and often recur, especially with repeated infections from a long incubation period of HPV.

Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_77837

  • However, low diagnostic rate due to lack of awareness may hamper the market. The prevalence of warts is higher among the population; however, the diagnosis rate is low in patients. For instance, according to the Health Protection Report, in England in 2018, the rate of genital warts diagnosis among girls aged 15 to 17 years attending sexual health services decreased 92%, as compared to that in 2014. Moreover, existing treatment procedures are often painful or invasive, can have undesirable outcomes such as scarring or dyspigmentation, and often require repeat visits. This results in a decrease in the diagnostic rate, which in turn, is likely to restrain the warts therapeutics market.

Request for Analysis of COVID-19 Impact on Genital Warts Therapeutics Market- https://www.transparencymarketresearch.com/sample/sample.php?flag=covid19&rep_77837

Physical destruction segment to dominate the global genital warts therapeutics market

  • Based on treatment type, the global genital warts therapeutics market can be divided into physical destruction, chemical destruction, and immunomodulation
  • The physical destruction segment dominated the global genital warts therapeutics market, in terms of revenue, in 2019. Currently, physical destruction, such as cryotherapy represents the first line of therapy treatment for genital warts, which provides cure rates between 50% and 80%.
  • However, the immunomodulation segment is expected to expand at a notable CAGR during the forecast period. Loss cost therapy, easy availability of drugs, and extensive ongoing research & development on immunomodulator drugs for the treatment of warts are expected to launch during the forecast period. For instance, immunomodulator candidate CB-06-02 from Cassiopea Inc., is likely to drive the segment from 2020 to 2030.

Request for Custom Research - https://www.transparencymarketresearch.com/sample/sample.php?flag=CR&rep_77837

Clinics segment witnessed significant expansion

  • Based on end user, the global genital warts therapeutics market can be divided into hospitals, clinics, and others
  • The clinics segment accounted for a prominent share of the global genital warts therapeutics market in 2019. It is estimated to expand at a notable CAGR during the forecast period. Preference for outpatient treatment to avoid hospital stay is a key factor that is likely to augment the segment. Increase in number of clinics with advanced treatment options for warts is anticipated to drive the segment.
  • High cost of treatment and long duration of stay in the hospital for the treatment is likely to hamper the hospital segment. The others segment primarily includes homecare and ambulatory surgical centers. Rise in popularity of ambulatory surgical centers and increasing use of OTC products are major factors driving the segment.

Pre Book Genital Warts Therapeutics Market Report - https://www.transparencymarketresearch.com/checkout.php?rep_77837&ltype=S

North America is estimated to dominate the Global Genital Warts Therapeutics Market

  • In terms of region, the global genital warts therapeutics market can be divided into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
  • In terms of revenue, North America dominated the genital warts therapeutics market followed by Europe. Well-established health care infrastructure, early adoption of advanced products, and presence of key players are major factors that are anticipated to drive the market in the region. Moreover, focus on research & development by leading players is expected to boost the market.
  • However, the market in Asia Pacific is estimated to expand at a prominent CAGR during the forecast period due to a significantly large patient population, which is rising. Improvement in health care infrastructure and increase in prevalence of warts are anticipated to drive the market in the region in the near future. According to an article published in the Infectious Agents and Cancer, a study conducted during 2011 to 2012 in the Philippines, the prevalence of genital warts stood at 4.78%; the prevalence was higher among men than women for all age groups.

Key Manufacturers Operating in Market

The global genital warts therapeutics market was highly fragmented in 2019.

More Trending Reports by Transparency Market Research:

Viral Vaccines Market Vaccines are biological preparations, generally produced from living organisms, which enhance immunity against a particular disease. Vaccines that prevent occurrence of a disease are called prophylactic vaccines and in some cases, those that treat diseases are called therapeutic vaccines.

Dental Calipers Market Direct measurement of casts using calipers has been accepted as the clinical standard for linear measurements. Measurements on these systems have been extensively compared with digital calipers and have been found to be clinically acceptable. A long caliper is highly convenient for its user friendliness but does require some care in use.

Transfer Mattress Market The word mattress is derived from Arabic, which means ‘something thrown down’ or ‘place where something is thrown down’. Transfer mattresses are of great significance, as they are employed for transporting a patient safely. The mattress includes handles to lift the patient on to a stretcher. Transfer mattresses have safety straps and a thermal guard to provide safety to patients. Early mattresses were made from various natural materials such as straw, feathers, or horse hair.

About Us

Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.

Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through ad hoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.

TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.

Contact
Mr. Rohit Bhisey
Transparency Market Research
State Tower,
90 State Street,
Suite 700,
Albany NY - 12207
United States
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: https://www.transparencymarketresearch.com/